Effect of chronic administration of magnesium sulfate on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

被引:10
|
作者
Tariq, M [1 ]
Khan, HA [1 ]
Al Moutaery, K [1 ]
Al Deeb, SM [1 ]
机构
[1] Armed Forces Hosp, Riyadh 11159, Saudi Arabia
来源
PHARMACOLOGY & TOXICOLOGY | 1998年 / 82卷 / 05期
关键词
D O I
10.1111/j.1600-0773.1998.tb01428.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This investigation was aimed to study the effect of magnesium on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice. Four groups of mice were given magnesium sulfate (MgSO4 . 7H(2)O) in drinking water at four different concentrations of 0.0 g/l (control), 2.5 g/l (low), 5.0 g/l (medium) and 10.0 g/l thigh) respectively for a period of 16 weeks: these animals also received MPTP (30 mg/kg, intraperitoneally daily) during the last five days of Mg treatment. Other four groups of mice were given similar dose regimen of MgSO4 but received injections of saline instead of MPTP. Seventy-two hr after the last dose of MPTP, neurobehavioural studies including locomotor activity, pole climbing test and heat nociception test were performed and striata were collected for the analysis of dopamine. The results of this study show that treatment of mice with MgSO4 or MPTP individually has no effect on their behaviour. Concomitant administration of low dose of MgSO4 (2.5 g/l) along with MPTP produced increase in motor activity and latency to heat stimuli; whereas medium and high doses of MgSO4 in combination with MPTP produced opposite las compared to low dose) effects resulting in a decrease in motor activity and latency to heat stimuli and increase in pole climbing time. However, MgSO4 dose-dependently exacerbated MPTP-induced depletion of striatal dopamine. The mortality was drastically increased (30-55%) in the animals receiving combined treatments of MPTP and MgSO, as compared to the mice treated with MPTP alone (12%). This study clearly points towards the ability of MgSO4 to modify MPTP-induced neurotoxicity.
引用
收藏
页码:218 / 222
页数:5
相关论文
共 50 条
  • [21] The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum
    Seung-Tae Kim
    Woongjoon Moon
    Younbyoung Chae
    Youn Jung Kim
    Hyejung Lee
    Hi-Joon Park
    The Journal of Physiological Sciences, 2010, 60 : 27 - 34
  • [22] Unexpected Neuroprotective Effects of Loganin on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Neurotoxicity and Cell Death in Zebrafish
    Yao, Li
    Peng, Shi-Xiao
    Xu, Yi-Da
    Lin, Stanley Li
    Li, Yu-Hong
    Liu, Chun-Jie
    Zhao, Hou-De
    Wang, Lin-Fang
    Shen, Yan-Qin
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (03) : 615 - 628
  • [23] Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity
    Hare, Dominic J.
    Adlard, Paul A.
    Doble, Philip A.
    Finkelstein, David I.
    METALLOMICS, 2013, 5 (02) : 91 - 109
  • [24] SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
    Muralikrishnan, D
    Ebadi, M
    BRAIN RESEARCH, 2001, 892 (02) : 241 - 247
  • [25] Rosmarinic acid protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in zebrafish embryos
    Zhao, Yue
    Han, Yingjie
    Wang, Zhenhua
    Chen, Tianrong
    Qian, Haowen
    He, Jie
    Li, Ji
    Han, Bing
    Wang, Tian
    TOXICOLOGY IN VITRO, 2020, 65
  • [26] Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
    Stefan Lorenzl
    Noel Calingasan
    Lichuan Yang
    David S. Albers
    Shuei Shugama
    Jason Gregorio
    H. W. Krell
    Jason Chirichigno
    Tong Joh
    M. Flint Beal
    NeuroMolecular Medicine, 2004, 5 : 119 - 131
  • [27] Adaptive acetylcholinesterase splicing patterns attenuate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
    Ben-Shaul, Y.
    BenMoyal-Segal, L.
    Ben-Ari, S.
    Bergman, H.
    Soreq, H.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2006, 23 (11) : 2915 - 2922
  • [28] Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice
    Lorenzl, S
    Calingasan, N
    Yang, LC
    Albers, DS
    Shugama, S
    Gregorio, J
    Krell, HW
    Chirichigno, J
    Joh, T
    Beal, MF
    NEUROMOLECULAR MEDICINE, 2004, 5 (02) : 119 - 131
  • [29] Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization
    Itzhak, Y
    Martin, JL
    Black, MD
    Ali, SF
    NEUROPHARMACOLOGY, 1998, 37 (06) : 781 - 791
  • [30] e-Cadherin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson Disease
    Cataldi, Samuela
    Codini, Michela
    Hunot, Stephane
    Legeron, Francois-Pierre
    Ferri, Ivana
    Siccu, Paola
    Sidoni, Angelo
    Ambesi-Impiombato, Francesco Saverio
    Beccari, Tommaso
    Curcio, Francesco
    Albi, Elisabetta
    MEDIATORS OF INFLAMMATION, 2016, 2016